These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15613439)

  • 1. High-resolution serum proteomic patterns for ovarian cancer detection.
    Baggerly KA; Edmonson SR; Morris JS; Coombes KR
    Endocr Relat Cancer; 2004 Dec; 11(4):583-4; author reply 585-7. PubMed ID: 15613439
    [No Abstract]   [Full Text] [Related]  

  • 2. Translational Research and Plasma Proteomic in Cancer.
    Santini AC; Giovane G; Auletta A; Di Carlo A; Fiorelli A; Cito L; Astarita C; Giordano A; Alfano R; Feola A; Di Domenico M
    J Cell Biochem; 2016 Apr; 117(4):828-35. PubMed ID: 26479787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SELDI-TOF MS profiling of plasma proteins in ovarian cancer.
    Wu SP; Lin YW; Lai HC; Chu TY; Kuo YL; Liu HS
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):26-32. PubMed ID: 17272204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer in the proteomics era.
    Annunziata CM; Azad N; Dhamoon AS; Whiteley G; Kohn EC
    Int J Gynecol Cancer; 2008; 18 Suppl 1():1-6. PubMed ID: 18336391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A data review and re-assessment of ovarian cancer serum proteomic profiling.
    Sorace JM; Zhan M
    BMC Bioinformatics; 2003 Jun; 4():24. PubMed ID: 12795817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Design, Randomization, and Validation.
    Baggerly K
    Clin Chem; 2018 Oct; 64(10):1534-1535. PubMed ID: 29776951
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteomic patterns to identify ovarian cancer: 3 years on.
    Diamandis EP
    Expert Rev Mol Diagn; 2004 Sep; 4(5):575-7. PubMed ID: 15347249
    [No Abstract]   [Full Text] [Related]  

  • 9. Proteomics success story. Towards early detection of breast and ovarian cancer: plasma proteomics as a tool to find novel markers.
    Souchelnytskyi S; Lomnytska M; Dubrovska A; Hellman U; Volodko N
    Proteomics; 2006 Sep; 6 Suppl 2():65-8. PubMed ID: 17031801
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteomic patterns in serum and identification of ovarian cancer.
    Rockhill B
    Lancet; 2002 Jul; 360(9327):169; author reply 170-1. PubMed ID: 12126842
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated approach utilizing proteomics and bioinformatics to detect ovarian cancer.
    Yu JK; Zheng S; Tang Y; Li L
    J Zhejiang Univ Sci B; 2005 Apr; 6(4):227-31. PubMed ID: 15754417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modifications.
    Liu C; Shea N; Rucker S; Harvey L; Russo P; Saul R; Lopez MF; Mikulskis A; Kuzdzal S; Golenko E; Fishman D; Vonderheid E; Booher S; Cowen EW; Hwang ST; Whiteley GR
    Proteomics; 2007 Nov; 7(22):4045-52. PubMed ID: 17952875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer.
    Baggerly KA; Morris JS; Edmonson SR; Coombes KR
    J Natl Cancer Inst; 2005 Feb; 97(4):307-9. PubMed ID: 15713966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics of ovarian cancer: functional insights and clinical applications.
    Elzek MA; Rodland KD
    Cancer Metastasis Rev; 2015 Mar; 34(1):83-96. PubMed ID: 25736266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of epithelial ovarian cancer using a proteomics-based protein-profiling approach combined with a novel selection strategy.
    Kothandaraman N; Bajic VB; Loganath A; Koh S; Ng J; Choolani M; Razvi K
    Ann Acad Med Singap; 2004 Sep; 33(5 Suppl):S59-60. PubMed ID: 15651211
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proteomics and biomarkers for detection of ovarian cancer].
    Kacerovský M; Tambor V; Lenco J; Tosner J
    Ceska Gynekol; 2009 Jun; 74(3):163-70. PubMed ID: 19642513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer: biomarker proteomic diagnosis in progress.
    Zhang Y; Guo B; Bi R
    Appl Biochem Biotechnol; 2012 Oct; 168(4):910-6. PubMed ID: 22945560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical proteomics and biomarker discovery.
    Johann DJ; McGuigan MD; Patel AR; Tomov S; Ross S; Conrads TP; Veenstra TD; Fishman DA; Whiteley GR; Petricoin EF; Liotta LA
    Ann N Y Acad Sci; 2004 Jun; 1022():295-305. PubMed ID: 15251975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
    Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.